Mapping the Safety Profile of BiologicalsA Disproportionality Analysis Using the WHO Adverse Drug Reaction Database, VigiBase

被引：0

作者：

Thijs J. Giezen

Aukje K. Mantel-Teeuwisse

Ronald H.B. Meyboom

Sabine M.J.M. Straus

Hubert G.M. Leufkens

Toine C.G. Egberts

机构：

[1] Utrecht University,Utrecht Institute for Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology

[2] Medicines Evaluation Board,WHO Collaborating Centre for International Drug Monitoring

[3] Uppsala Monitoring Centre,Department of Clinical Pharmacy

[4] University Medical Center Utrecht,undefined

来源：

Drug Safety | 2010年 / 33卷

关键词：

Infliximab; Etanercept; Adalimumab; Teriparatide; System Organ Class;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Background: Biologicals have specific characteristics, as compared with the small molecule drugs, and carry specific risks. Safety problems, for example infliximab and the risk for tuberculosis, have been identified via spontaneous reports of suspected adverse drug reactions (ADRs). However, in general there is limited data on the nature of spontaneously reported suspected ADRs for biologicals.

引用

页码：865 / 878

页数：13

共 50 条

[21] Adverse drug reactions reports for trastuzumab: an analysis of Brazilian pharmacovigilance database and VigiBase®/WHO and EudraVigilance/EMA
Barcelos, F.
Matos, G.
Costa Lima-Dellamora, E.
DRUG SAFETY, 2017, 40 (10) : 1006 - 1007
[22] THROMBOEMBOLIC SAFETY PROFILE OF TOFACITINIB AND BARICITINIB: AN ANALYSIS OF WHO VIGIBASE
Vallejo-Yague, E.
Weiler, S.
Burden, A. M.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 150 - 150
[23] Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports
Conte, Cecile
Rousseau, Vanessa
Vert, Charlotte
Montastruc, Francois
Montastruc, Jean-Louis
Durrieu, Genevieve
Olivier, Pascale
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2020, 34 (04) : 518 - 520
[24] Ototoxic Adverse Drug Reactions: A Disproportionality Analysis Using the Italian Spontaneous Reporting Database
Barbieri, Maria Antonietta
Cicala, Giuseppe
Cutroneo, Paola Maria
Mocciaro, Eleonora
Sottosanti, Laura
Freni, Francesco
Galletti, Francesco
Arcoraci, Vincenzo
Spina, Edoardo
FRONTIERS IN PHARMACOLOGY, 2019, 10
[25] Major Adverse Cardiovascular Events Related to Jak Inhibitors: A Disproportionality Analysis Using WHO Global Individual Case Safety Database
Di Napoli, Raffaella
Richez, Christophe
Scavone, Cristina
Singier, Allison
Demorgues, Maxime
Mascolo, Annamaria
Capuano, Annalisa
Salvo, Francesco
DRUG SAFETY, 2024, 47 (12) : 1395 - 1395
[26] Dual Orexin Receptor Antagonists Versus Z-drugs: a Disproportionality Analysis Using WHO Drug Safety Database
Cicala, Giuseppe
Gauld, Christophe
Micoulaud-Franchi, Jean-Arthur
Salvo, Francesco
DRUG SAFETY, 2024, 47 (12) : 1406 - 1406
[27] Cardiovascular Toxicities Associated with Anaplastic Lymphoma Kinase Inhibitors: A Disproportionality Analysis of the WHO Pharmacovigilance Database (VigiBase)
Takahiro Niimura
Koji Miyata
Hirofumi Hamano
Yuuki Nounin
Hiroto Unten
Masaki Yoshino
Satoru Mitsuboshi
Fuka Aizawa
Kenta Yagi
Toshihiro Koyama
Mitsuhiro Goda
Yasunari Kanda
Yuki Izawa-Ishizawa
Yoshito Zamami
Keisuke Ishizawa
Drug Safety, 2023, 46 : 545 - 552
[28] Adverse Drug Reactions of Biologicals: Evaluation of a New Classification System Using the WHO-ADR Database Vigibase
Giezen, T. J.
Mantel-Teeuwisse, A. K.
De Bruin, M. L.
Straus, S. M. J. M.
Leufkens, H. G. M.
Egberts, A. C. G.
DRUG SAFETY, 2010, 33 (10) : 912 - 912
[29] Evaluation of a Proposed Classification System for Adverse Drug Reactions for Biologicals Using The WHO-ADR Database VigiBase
Giezen, Thijs
Mantel-Teeuwisse, Aukje
Straus, Sabine
Leufkens, Bert
Egberts, Toine
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S126 - S127
[30] Dementia and Alzheimer's Disease Associated With Aromatase Inhibitors: A Disproportionality Analysis of the WHO Pharmacovigilance Database (VigiBase)
Yuste, Maria Teresa
Sainz-Gil, Maria
Escudero, Elisa
Marin, Pedro
PHARMACOLOGY RESEARCH & PERSPECTIVES, 2025, 13 (01):

← 1 2 3 4 5 →